HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 604 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $11,803,791 | -21.6% | 103,724 | -57.3% | 1.03% | -25.9% |
Q3 2022 | $15,047,000 | -12.0% | 243,121 | +13.5% | 1.40% | -13.6% |
Q2 2022 | $17,091,000 | -32.3% | 214,277 | -10.7% | 1.62% | -10.1% |
Q1 2022 | $25,243,000 | +45.4% | 239,925 | +49.0% | 1.80% | +63.6% |
Q4 2021 | $17,356,000 | +6.9% | 161,063 | +8.6% | 1.10% | -7.4% |
Q3 2021 | $16,239,000 | -23.9% | 148,245 | -34.9% | 1.19% | -11.4% |
Q2 2021 | $21,335,000 | -14.3% | 227,839 | -15.8% | 1.34% | -22.9% |
Q1 2021 | $24,909,000 | +19.5% | 270,631 | -5.1% | 1.74% | +7.8% |
Q4 2020 | $20,851,000 | +1.5% | 285,046 | +7.8% | 1.61% | -27.4% |
Q3 2020 | $20,535,000 | +619.0% | 264,356 | +414.5% | 2.22% | +282.8% |
Q2 2020 | $2,856,000 | -40.4% | 51,379 | -68.2% | 0.58% | -37.8% |
Q1 2020 | $4,788,000 | -32.0% | 161,664 | -16.9% | 0.93% | +28.6% |
Q4 2019 | $7,039,000 | -29.0% | 194,439 | -46.6% | 0.72% | -13.1% |
Q3 2019 | $9,915,000 | +95.1% | 364,117 | +72.4% | 0.83% | +79.0% |
Q2 2019 | $5,081,000 | – | 211,178 | – | 0.47% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |